RTW INVESTMENTS, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001493215
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 81 positions · Total reported value $9.91B · Top-10 concentration 43.5% · Updated 2026-11-16
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
Turnover: 37.2% · 10 new · 12 cut · 13 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, RTW INVESTMENTS, LP disclosed 81 equity positions with a combined reported value of $9.91B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were PTGX ($713.07M), ARGX ($682.35M), CGON ($603.60M). By sector, the heaviest allocations are Health Care 99.0%, Industrials 0.5%.
Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions. The portfolio's overlap with the prior quarter was 76% of names.
The largest new positions opened in Q3 2026 were VRDN ($102.03M), ANIX ($28.06M), PYXS ($15.16M).
Of the 13 positions fully exited versus the prior quarter, the largest were ALKS ($87.62M), DFTX ($18.82M), IDYA ($13.80M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- VRDN VIRIDIAN THERAPEUTICS INC · $102.03M
- ANIX KORSANA BIOSCIENCES INC · $28.06M
- PYXS PYXIS ONCOLOGY INC · $15.16M
- SRZN SURROZEN INC · $12.66M
- ARTV LATIGO BIOTHERAPEUTICS INC · $11.69M
- SLN SILENCE THERAPEUTICS PLC · $7.65M
- VNDA VANDA PHARMACEUTICALS INC · $5.98M
- DYN DYNE THERAPEUTICS INC · $4.83M
Fully Exited (vs previous quarter)
- ALKS ALKERMES PLC · prev qtr: $87.62M
- DFTX DEFINIUM THERAPEUTICS INC · prev qtr: $18.82M
- IDYA IDEAYA BIOSCIENCES INC · prev qtr: $13.80M
- ATAI Ataibeckley Inc CVR · prev qtr: $10.54M
- TENX TENAX THERAPEUTICS INC · prev qtr: $10.14M
- PCSC PERCEPTIVE CAP SOLUTIONS COR · prev qtr: $8.08M
- WVE WAVE LIFE SCIENCES INC · prev qtr: $7.84M
- FDMT 4D MOLECULAR THERAPEUTICS IN · prev qtr: $6.33M
Insider Transactions (Form 4)
Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-11-09 | Buy | Orchestra BioMed Holdings, Inc. | 1,200,000 | $5.00 | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 1,771 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 19,934 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 161,807 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 209,254 | — | SEC filing |
| 2026-04-27 | Sell | Orchestra BioMed Holdings, Inc. | 32 | $4.13 | SEC filing |
| 2026-04-27 | Opt exercise | Orchestra BioMed Holdings, Inc. | 1,250,032 | $0.00 | SEC filing |
| 2026-04-20 | Buy | Kailera Therapeutics, Inc. | 500,000 | $16.00 | SEC filing |
Fund Profile
RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-78183 (status: Approved), registered 2013-06-13
- Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 2 hedge funds
- Website: rtwfunds.com
Portfolio Structure
- 84 positions · $11.71B reported value (Q2 2026)
- Top 10 holdings = 47.7% of reported value
- Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
- Average position size: $139.44M
Sector Tilt
- Health Care 99.1%
- Industrials 0.4%
- Information Technology 0.4%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
- 43 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 03:54
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.06M | $713.07M | 7.20% | Hold | |
| 2 |
|
711.58K | $682.35M | 6.89% | Hold | |
| 3 |
|
8.51M | $603.60M | 6.09% | Hold | |
| 4 |
|
3.12M | $354.50M | 3.58% | Add | |
| 5 |
|
3.10M | $353.44M | 3.57% | Reduce | |
| 6 |
|
14.05M | $350.51M | 3.54% | Add | |
| 7 |
|
22.45M | $329.07M | 3.32% | Add | |
| 8 |
|
3.69M | $328.68M | 3.32% | Reduce | |
| 9 |
|
4.63M | $319.24M | 3.22% | Reduce | |
| 10 |
|
3.48M | $273.88M | 2.76% | Add | |
| 11 |
|
10.35M | $272.64M | 2.75% | Add | |
| 12 |
|
1.39M | $266.32M | 2.69% | Add | |
| 13 |
|
1.48M | $264.16M | 2.67% | Hold | |
| 14 |
|
3.30M | $262.81M | 2.65% | Hold | |
| 15 |
|
3.14M | $261.45M | 2.64% | Hold | |
| 16 |
|
600.00K | $247.99M | 2.50% | Reduce | |
| 17 |
|
2.86M | $188.63M | 1.90% | Hold | |
| 18 |
|
4.54M | $184.62M | 1.86% | Hold | |
| 19 |
|
2.67M | $171.06M | 1.73% | Hold | |
| 20 |
|
6.83M | $170.35M | 1.72% | Add | |
| 21 |
|
312.82K | $157.65M | 1.59% | Reduce | |
| 22 |
|
4.87M | $147.51M | 1.49% | Hold | |
| 23 |
|
5.62M | $146.21M | 1.48% | Hold | |
| 24 |
|
7.14M | $143.96M | 1.45% | Hold | |
| 25 |
|
1.49M | $141.06M | 1.42% | Hold | |
| 26 |
|
5.93M | $139.33M | 1.41% | Hold | |
| 27 |
|
10.95M | $136.20M | 1.37% | Add | |
| 28 |
|
942.68K | $133.71M | 1.35% | Reduce | |
| 29 |
|
8.53M | $128.20M | 1.29% | Add | |
| 30 |
|
10.78M | $123.07M | 1.24% | Hold | |
| 31 |
|
715.33K | $121.48M | 1.23% | Hold | |
| 32 |
|
13.52M | $118.72M | 1.20% | Add | |
| 33 |
|
8.49M | $112.43M | 1.14% | Add | |
| 34 |
|
3.18M | $107.35M | 1.08% | Hold | |
| 35 |
|
1.62M | $104.67M | 1.06% | Reduce | |
| 36 |
|
4.98M | $102.03M | 1.03% | New | |
| 37 |
|
2.78M | $98.71M | 1.00% | Hold | |
| 38 |
|
3.94M | $95.23M | 0.96% | Hold | |
| 39 |
|
2.31M | $73.93M | 0.75% | Hold | |
| 40 |
|
2.28M | $71.36M | 0.72% | Add | |
| 41 |
|
1.66M | $69.56M | 0.70% | Add | |
| 42 |
|
13.56M | $66.04M | 0.67% | Hold | |
| 43 |
|
9.56M | $59.44M | 0.60% Form 4 · 1 → |
Hold | |
| 44 |
|
6.72M | $54.08M | 0.55% | Add | |
| 45 |
|
230.00K | $50.96M | 0.51% | Hold | |
| 46 |
|
500.00K | $48.62M | 0.49% | Hold | |
| 47 |
|
17.69M | $46.52M | 0.47% | Hold | |
| 48 |
|
5.91M | $42.70M | 0.43% | Add | |
| 49 |
|
1.51M | $42.08M | 0.42% | Add | |
| 50 |
|
2.36M | $36.29M | 0.37% | Hold | |
FAQ
What did RTW INVESTMENTS, LP buy in 2026-Q3?
In its 2026-Q3 13F filing, RTW INVESTMENTS, LP reported 81 equity positions worth $9.91B in aggregate; its largest disclosed positions were PTGX ($713.07M), ARGX ($682.35M), CGON ($603.60M).
How large is RTW INVESTMENTS, LP's portfolio?
RTW INVESTMENTS, LP reported $9.91B of long equity holdings across 81 positions as of 2026-Q3. Top-10 holdings account for 43.5% of reported value.
What is RTW INVESTMENTS, LP's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.